Fiorenza Enrico

Candiolo Cancer Institute

Papers

1

Total Citations

16

H-Index

1

About

Enrico Fiorenza is a leading figure in oncology pharmacy practice, with a focused research agenda on the automation and optimization of chemotherapy drug preparation. His most-cited work, a 2021 study on robotic compounding in an Italian comprehensive cancer center, has garnered 16 citations and stands as a landmark contribution to the field. In this study, Fiorenza demonstrated how implementing robotic systems can dramatically increase pharmacy productivity while simultaneously reducing medication turnaround times—a critical advancement for high-volume cancer centers managing escalating workloads. His research addresses the high-risk nature of antineoplastic drug management, offering evidence-based solutions that enhance both operational efficiency and patient safety. By documenting the successful centralization of satellite pharmacy activities through automation, Fiorenza has provided a replicable model for oncology pharmacies worldwide. His work bridges the gap between clinical pharmacy and industrial engineering, making him a key voice in the movement toward safer, more efficient cancer care delivery systems. For students and researchers in pharmacy practice, health systems, or oncology, Fiorenza’s contributions offer a compelling case study in how technology can transform high-stakes clinical workflows.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Increasing pharmacy productivity and reducing medication turnaround times in an Italian comprehensive cancer center by implementing robotic chemotherapy drugs compounding
16 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Candiolo Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago